Istanbul, Türkiye
Research view
Hypothyroidism: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- PD-1 0
- PD-L1 0
- CD20 0
- AMPK 0
- PTEN 0
- ABL1 0
- AQP4 0
- BRAF 0
- CTLA-4 0
- EGFR 0
- GLP-1 0
- IL-1 0
- IL-6 0
- NRAS 0
- NRF2 0
- PIK3CA 0
- PNPLA3 0
- PSMA 0
- STAT3 0
- TNF 0
- VEGF 0
EU-13 is a filter, not a ranking: it only narrows the list.
Cambridge, United States
Alexandria, Egypt
Rochester, United States
Los Angeles, United States
Athens, Greece
Tashkent, Uzbekistan
Chinese Academy of Medical Sciences & Peking Union Medical College · Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Lancet Gastroenterol Hepatol, Nov 2025Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial.
Chicago, United States
Baltimore, United States
Chengdu, China
Dhaka, Bangladesh
Ann Arbor, United States
Guangzhou, China
Doha, Qatar
Galveston, United States
Rotterdam, Netherlands
Fuzhou, China
Beijing, China
Chengdu, China
Fudan University · Shanghai, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Lancet Gastroenterol Hepatol, Nov 2025Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial.
Philadelphia, United States
New Delhi, India
Tehran, Iran
24 of 1,171 institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
“Inability to recruit subjects”Registry text, quoted unchanged. Source
Withdrawn
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
“It was determined that a study is no longer required because the clinical question posed by the study has been answered through published literature”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 1
- Organoids 2
- Mendelian Randomization Analysis 32
- Gene Expression Profiling 7
- Sequence Analysis, RNA 1
- Exome Sequencing 11
- Proteomics 1
- Metabolomics 6
- Mass Spectrometry 5
- Flow Cytometry 1
- Immunohistochemistry 9
- Positron-Emission Tomography 2
- Magnetic Resonance Imaging 25
- Machine Learning 11
- Deep Learning 1
- Cohort Studies 86
- Genome-Wide Association Study 39
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.